Author details

Full Name

Douglas Galasko

Affiliation

ORCID

Career Start Year

1986

Papers

433

H Index

114

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37464962	The MINT Sprint 2.0: A picture naming test for detection of naming impairments in Alzheimer's disease and in preclinical AD.	Alzheimers Dement	2024
37827916	Association Between Self- and Proxy-Reported Depression and Quality of Life in Mild-Moderate Alzheimer's Disease.	Am J Geriatr Psychiatry	2024
37740924	ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium.	Alzheimers Dement	2024
36780762	APOE differentially moderates cerebrospinal fluid and plasma phosphorylated tau181 associations with multi-domain cognition.	Neurobiol Aging	2023
35925735	Autocorrection ifâ¿¿of function words in reading aloud: A novel marker of Alzheimer's risk.	Neuropsychology	2023
37853256	Author Correction: Enhancing untargeted metabolomics using metadata-based source annotation.	Nat Biotechnol	2023
37924159	Limitations of the human iPSC-derived neuron model for early-onset Alzheimer's disease.	Mol Brain	2023
37694991	The potential clinical value of plasma biomarkers in Alzheimer's disease.		2023
37614206	Assessments of the Utilities of CSF NPTX2 for Disease Progression in Cognitively Normal Individuals Who Progress to Clinical MCI and AD.	Ann Neurol	2023
37154939	Tau seeds occur before earliest Alzheimer's changes and are prevalent across neurodegenerative diseases.		2023
36774388	A proteogenomic view of Parkinson's disease causality and heterogeneity.	NPJ Parkinsons Dis	2023
37461624	Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies <i>LRRC4C, LHX5-AS1</i> and nominates ancestry-specific loci <i>PTPRK</i> , <i>GRB14</i> , and <i>KIAA0825</i> as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics Consortium.	medRxiv	2023
37458046	Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease Progression.	J Parkinsons Dis	2023
36572122	Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration.		2023
36946611	SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease.		2023
36873923	Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panel.	Alzheimers Dement (N Y)	2023
36939111	Comparison of the telephone-Montreal Cognitive Assessment (T-MoCA) and Telephone Interview for Cognitive Status (TICS) as screening tests for early Alzheimer's disease.	Alzheimers Dement	2023
37376619	Alzheimer's Disease Pathology in Middle Aged and Older People with HIV: Comparisons with Non-HIV Controls on a Healthy Aging and Alzheimer's Disease Trajectory and Relationships with Cognitive Function.	Viruses	2023
37059509	Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using Î±-synuclein seed amplification: a cross-sectional study.	Lancet Neurol	2023
35084109	Endotype reversal as a novel strategy for screening drugs targeting familial Alzheimer's disease.	Alzheimers Dement	2022
35768637	Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression.	Mol Psychiatry	2022
35386474	The neuroinflammatory marker sTNFR2 relates to worse cognition and tau in women across the Alzheimer's disease spectrum.	Alzheimers Dement (Amst)	2022
36224601	Transcriptomic profiling of sporadic Alzheimer's disease patients.	Mol Brain	2022
36028327	Perception of Fragmented Letters by Patients With Pathologically Confirmed Dementia With Lewy Bodies or Alzheimer Disease.	Neurology	2022
35696592	TDP-43 Pathology Exacerbates Cognitive Decline in Primary Age-Related Tauopathy.	Ann Neurol	2022
35573689	Differential Effects of APOE Genotype on MicroRNA Cargo of Cerebrospinal Fluid Extracellular Vesicles in Females With Alzheimer's Disease Compared to Males.	Front Cell Dev Biol	2022
36281670	Alzheimer's Disease Clinical Trial Research Adaptation Following COVID-19 Pandemic Onset: National Sample of Alzheimer's Clinical Trial Consortium Sites.	J Prev Alzheimers Dis	2022
35798960	Enhancing untargeted metabolomics using metadata-based source annotation.	Nat Biotechnol	2022
36269086	Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies.	J Neuropathol Exp Neurol	2022
35733234	Performance of Î±Synuclein RT-QuIC in relation to neuropathological staging of Lewy body disease.	Acta neuropathologica communications	2022
35987203	Warburg-like metabolic transformation underlies neuronal degeneration in sporadic Alzheimer's disease.	Cell Metab	2022
36324151	Sex differences in Alzheimer's disease: plasma MMP-9 and markers of disease severity.	Alzheimers Res Ther	2022
35980456	Selective tau seeding assays and isoform-specific antibodies define neuroanatomic distribution of progressive supranuclear palsy pathology arising in Alzheimer's disease.	Acta Neuropathol	2022
35404285	Spillover: The Approval of New Medications for Alzheimer's Disease Dementia Will Impact Biomarker Disclosure Among Asymptomatic Research Participants.	J Alzheimers Dis	2022
36449427	Lack of Benefit of Iron Chelation in Early Parkinson's Disease.	New England Journal of Medicine	2022
35779041	Blood extracellular vesicles carrying synaptic function- and brain-related proteins as potential biomarkers for Alzheimer's disease.	Alzheimers Dement	2022
36516855	Cerebrospinal fluid immune dysregulation during healthy brain aging and cognitive impairment.	Cell	2022
36490316	SOBA: Development and testing of a soluble oligomer binding assay for detection of amyloidogenic toxic oligomers.	Proc Natl Acad Sci U S A	2022
36459967	Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer's disease.	Cell Stem Cell	2022
34847258	Long-standing multiple system atrophy-Parkinsonism with limbic and FTLD-type Î±-synuclein pathology.	Neuropathol Appl Neurobiol	2022
35173668	Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium.	Front Neurol	2022
35147543	A Blood Test for Alzheimer's Disease: It's about Time or Not Ready for Prime Time?	J Alzheimers Dis	2022
34810247	Association of Neurofibrillary Tangle Distribution With Age at Onset-Related Clinical Heterogeneity in Alzheimer Disease: An Autopsy Study.	Neurology	2022
35349636	Proposed research criteria for prodromal behavioural variant frontotemporal dementia.	Brain	2022
35305329	Dynamics of neuroinflammation in Alzheimer's disease.	Lancet Neurology, The	2022
35195758	Plasma biomarkers for Alzheimer's Disease in relation to neuropathology and cognitive change.	Acta Neuropathol	2022
34692978	Objective subtle cognitive decline and plasma phosphorylated tau181: Early markers of Alzheimer's disease-related declines.	Alzheimers Dement (Amst)	2021
37118411	Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson's disease progression.	Nat Aging	2021
37117835	Active immunization in Alzheimer's disease.		2021
33860596	Elevated plasma neurofilament light predicts a faster rate of cognitive decline over 5 years in participants with objectively-defined subtle cognitive decline and MCI.	Alzheimers Dement	2021